Tags

Type your tag names separated by a space and hit enter

Antioxidant micronutrients for lung disease in cystic fibrosis.
Cochrane Database Syst Rev 2010; (12):CD007020CD

Abstract

BACKGROUND

Airway infection leads to progressive damage of the lungs in cystic fibrosis (CF), partly due to oxidative stress. Supplementation of antioxidant micronutrients (vitamin E, vitamin C, β-carotene and selenium) may help maintain an oxidant-antioxidant balance. Current literature suggests a relationship between oxidative status and lung function.

OBJECTIVES

To synthesize existing knowledge of the effect of vitamin C, vitamin E, β-carotene and selenium in CF lung disease.

SEARCH STRATEGY

The Cochrane CF and Genetic Disorders Group CF Trials Register, PubMed, CINAHL and AMED were searched using detailed search strategies. We contacted authors of included studies and checked reference lists of these studies for additional, potentially relevant studies.Last search of CF Trials Register: 09 September 2010.

SELECTION CRITERIA

Randomized controlled trials and quasi-randomized controlled trials of people with CF with explicitly stated diagnostic criteria, comparing vitamin E, vitamin C, β-carotene and selenium (individually or in combination) to placebo or standard care.

DATA COLLECTION AND ANALYSIS

Two authors independently selected trials, extracted data and assessed risk of bias. We contacted trialists to obtain missing information. Primary outcomes are lung function and quality of life; secondary outcomes are oxidative stress, inflammation, body mass index, days on antibiotics and adverse events during supplementation. If meta-analysed, studies were subgrouped according to combined or single antioxidant supplementation.

MAIN RESULTS

Four randomized controlled trials and one quasi-randomized controlled trial were included; only three trials (87 participants) presented data suitable for analysis. Based on two trials, there was no significant improvement in lung function; one trial indicated significant improvement in quality of life favouring control, mean difference -0.06 points on the quality of well-being scale (95% confidence interval -0.12 to -0.01). Based on two trials, selenium-dependent glutathione peroxidase enzyme significantly improved in favour of combined supplementation, mean difference 1.60 units per gram of haemoglobin (95% CI 0.30 to 2.90) and selenium supplementation, mean difference 10.20 units per gram of haemoglobin (95% CI 2.22 to 18.18). All plasma antioxidant levels, except vitamin C, significantly improved with supplementation.

AUTHORS' CONCLUSIONS

There appears to be conflicting evidence regarding the clinical effectiveness of antioxidant supplementation in CF. Based on the evidence, antioxidants appear to decrease quality of life and oxidative stress; however, few trials contributed data towards analysis. Further trials examining clinically important outcomes and elucidation of a clear biological pathway of oxidative stress in CF are necessary before a firm conclusion regarding effects of antioxidants supplementation can be drawn.

Authors+Show Affiliations

Ottawa Methods Centre, Clinical Epidemiology Program, Ottawa Hospital Research Institute, 501 Smyth Road, Box 208, Ottawa, Ontario, Canada, K1H 8L6.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Meta-Analysis
Review
Systematic Review

Language

eng

PubMed ID

21154377

Citation

Shamseer, Larissa, et al. "Antioxidant Micronutrients for Lung Disease in Cystic Fibrosis." The Cochrane Database of Systematic Reviews, 2010, p. CD007020.
Shamseer L, Adams D, Brown N, et al. Antioxidant micronutrients for lung disease in cystic fibrosis. Cochrane Database Syst Rev. 2010.
Shamseer, L., Adams, D., Brown, N., Johnson, J. A., & Vohra, S. (2010). Antioxidant micronutrients for lung disease in cystic fibrosis. The Cochrane Database of Systematic Reviews, (12), p. CD007020. doi:10.1002/14651858.CD007020.pub2.
Shamseer L, et al. Antioxidant Micronutrients for Lung Disease in Cystic Fibrosis. Cochrane Database Syst Rev. 2010 Dec 8;(12)CD007020. PubMed PMID: 21154377.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Antioxidant micronutrients for lung disease in cystic fibrosis. AU - Shamseer,Larissa, AU - Adams,Denise, AU - Brown,Neil, AU - Johnson,Jeffrey A, AU - Vohra,Sunita, Y1 - 2010/12/08/ PY - 2010/12/15/entrez PY - 2010/12/15/pubmed PY - 2011/2/11/medline SP - CD007020 EP - CD007020 JF - The Cochrane database of systematic reviews JO - Cochrane Database Syst Rev IS - 12 N2 - BACKGROUND: Airway infection leads to progressive damage of the lungs in cystic fibrosis (CF), partly due to oxidative stress. Supplementation of antioxidant micronutrients (vitamin E, vitamin C, β-carotene and selenium) may help maintain an oxidant-antioxidant balance. Current literature suggests a relationship between oxidative status and lung function. OBJECTIVES: To synthesize existing knowledge of the effect of vitamin C, vitamin E, β-carotene and selenium in CF lung disease. SEARCH STRATEGY: The Cochrane CF and Genetic Disorders Group CF Trials Register, PubMed, CINAHL and AMED were searched using detailed search strategies. We contacted authors of included studies and checked reference lists of these studies for additional, potentially relevant studies.Last search of CF Trials Register: 09 September 2010. SELECTION CRITERIA: Randomized controlled trials and quasi-randomized controlled trials of people with CF with explicitly stated diagnostic criteria, comparing vitamin E, vitamin C, β-carotene and selenium (individually or in combination) to placebo or standard care. DATA COLLECTION AND ANALYSIS: Two authors independently selected trials, extracted data and assessed risk of bias. We contacted trialists to obtain missing information. Primary outcomes are lung function and quality of life; secondary outcomes are oxidative stress, inflammation, body mass index, days on antibiotics and adverse events during supplementation. If meta-analysed, studies were subgrouped according to combined or single antioxidant supplementation. MAIN RESULTS: Four randomized controlled trials and one quasi-randomized controlled trial were included; only three trials (87 participants) presented data suitable for analysis. Based on two trials, there was no significant improvement in lung function; one trial indicated significant improvement in quality of life favouring control, mean difference -0.06 points on the quality of well-being scale (95% confidence interval -0.12 to -0.01). Based on two trials, selenium-dependent glutathione peroxidase enzyme significantly improved in favour of combined supplementation, mean difference 1.60 units per gram of haemoglobin (95% CI 0.30 to 2.90) and selenium supplementation, mean difference 10.20 units per gram of haemoglobin (95% CI 2.22 to 18.18). All plasma antioxidant levels, except vitamin C, significantly improved with supplementation. AUTHORS' CONCLUSIONS: There appears to be conflicting evidence regarding the clinical effectiveness of antioxidant supplementation in CF. Based on the evidence, antioxidants appear to decrease quality of life and oxidative stress; however, few trials contributed data towards analysis. Further trials examining clinically important outcomes and elucidation of a clear biological pathway of oxidative stress in CF are necessary before a firm conclusion regarding effects of antioxidants supplementation can be drawn. SN - 1469-493X UR - https://www.unboundmedicine.com/medline/citation/21154377/Antioxidant_micronutrients_for_lung_disease_in_cystic_fibrosis_ L2 - https://doi.org/10.1002/14651858.CD007020.pub2 DB - PRIME DP - Unbound Medicine ER -